In the last trading session, 2.49 million Agilon Health Inc (NYSE:AGL) shares changed hands as the company’s beta touched 0.59. With the company’s per share price at $11.52 changed hands at -$0.42 or -3.52% during last session, the market valuation stood at $4.68B. AGL’s last price was a discount, traded about -155.56% off its 52-week high of $29.44. The share price had its 52-week low at $10.80, which suggests the last value was 6.25% up since then. When we look at Agilon Health Inc’s average trading volume, we note the 10-day average is 4.23 million shares, with the 3-month average coming to 2.68 million.
Analysts gave the Agilon Health Inc (AGL) stock a consensus recommendation rating of a Buy, calculated at a mean rating of 1.25. If we narrow down to specifics, the data shows that 0 out of 16 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended AGL as a Hold, 14 felt it is a Buy and 0 rated the stock as Underweight. Agilon Health Inc’s EPS for the current quarter is expected to be -$0.13.
Agilon Health Inc (NYSE:AGL) trade information
Instantly AGL was in red as seen at the end of in last trading. With action 3.13%, the performance over the past five days has been green. The drop to weekly highs of 13.27 on Monday, 11/20/23 subtracted -3.52% to the stock’s daily price. The company’s shares are showing year-to-date downside of -28.62%, with the 5-day performance at 3.13% in the green. However, in the 30-day time frame, Agilon Health Inc (NYSE:AGL) is -40.43% down. Looking at the short shares, we see there were 46.38 million shares sold at short interest cover period of 23.62 days.
The consensus price target for the stock as assigned by Wall Street analysts is $22.31, meaning bulls need an upside of 48.36% from its current market value. According to analyst projections, AGL’s forecast low is $15.00 with $30.00 as the target high. To hit the forecast high, the stock’s price needs a -160.42% plunge from its current level, while the stock would need to soar -30.21% for it to hit the projected low.
Agilon Health Inc (AGL) estimates and forecasts
Data shows that the Agilon Health Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -45.25% over the past 6 months, a 23.08% in annual growth rate that is considerably higher than the industry average of 5.70%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2023 revenue estimates. The rating firms predict current quarter revenue for Agilon Health Inc will rise 7.10%, while the growth in revenue is estimated to hit 50.00% for the next quarter. Year-over-year growth is forecast to reach 67.00% up from the last financial year.
Consensus estimates given by 12 financial analysts project the company’s revenue in the current quarter to hit an average of $1.06 billion. 7 analysts are of the opinion that Agilon Health Inc’s revenue for the quarter ending Mar 2024 will be $1.47 billion. The company’s revenue for the corresponding quarters a year ago was $689.77 million and $1.14 billion respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 53.70%. The estimates for the next quarter sales put growth at 29.70%.
The 2023 estimates are for Agilon Health Inc earnings to increase by 56.41%.
Agilon Health Inc is expected to release its next quarterly earnings report on November 02.
Agilon Health Inc (NYSE:AGL)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.10% of Agilon Health Inc shares while 108.48% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 109.69%. There are 108.48% institutions holding the Agilon Health Inc stock share, with Clayton, Dubilier & Rice, LLC the top institutional holder. As of Jun 29, 2023, the company held 24.66% of the shares, roughly 100.0 million AGL shares worth $1.73 billion.
FMR, LLC holds the second largest percentage of outstanding shares, with 14.99% or 60.78 million shares worth $1.05 billion as of Jun 29, 2023.
Among Mutual Funds, the top two as of Jun 29, 2023 were New Economy Fund (The) and Vanguard Specialized-Health Care Fund. With 19.77 million shares estimated at $342.87 million under it, the former controlled 4.88% of total outstanding shares. On the other hand, Vanguard Specialized-Health Care Fund held about 4.70% of the shares, roughly 19.04 million shares worth around $364.67 million.